23andMe founder Anne Wojcicki set out in 2006 to disrupt the health care industry with a direct-to-consumer genetic testing service, but her plans were upset when the FDA stepped in. Wojcicki worked with regulators and the company has "quietly become the largest genetic study the world has ever known," says Stanford University cardiologist Euan Ashley, but it faces competition and Wojcicki must continue working to sustain customers' trust and prove that genetics-based drugs can work.
Sign up for FasterCures SmartBrief
Medical research news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.